pharmaceutical companies

Pharmacy Kiosks Could Be Coming

Nov 7, 2019
Pharmacy Technician amongst two shelves of prescription pills.
Daylina Miller/Health News Florida

The convenience of getting prescriptions filled at a kiosk could soon be a reality, under a bill moving through the state House.

But not everyone agrees it’s a good idea. 

There's a reckoning underway in the courts about the damage wrought by the opioid crisis and who should pay for it.

The Miami-Dade County School Board has filed a federal lawsuit against more than a dozen corporations that manufacture or distribute opioids, claiming that the nation’s fourth largest school district should be compensated for the money it has spent battling the “worst man-made epidemic in modern medical history.”

A federal judge on Monday stopped a Trump administration initiative that would have required drugmakers to reveal the sticker price of their drugs in television ads.

Under the rule, if a medicine's list price was more than $35 a month, it would have to be stated during the commercial. The challenge, opponents say, is that a drug's list price and estimates of what people can expect to pay vary widely depending on coverage.

Historian and Harvard professor Anne Harrington believes that pharmaceutical companies have played an oversized role in determining how mental illness is treated in the United States — leading to a rise in the use of antidepressant drugs.

Pharma Execs Dig In For A Fight Against Outraged Senators

Feb 27, 2019
Sarah Pusateri

Senators got their first opportunity Tuesday to prod drugmakers about the wallet-emptying prices they charge for prescription drugs. 

Researchers expect that three dozen new drugs will come on the market over the next few years with astronomical prices — some likely topping a million dollars per patient.

The drugmaker Novartis has told investors it might be able to charge $4 million to $5 million for one of its potential products, a treatment for a rare disease called spinal muscular atrophy.

Eight months pregnant, the drug sales representative wore a wire for the FBI around her bulging belly as she recorded conversations with colleagues at a conference in Chicago. Her code name? Pampers.

Prescription drugs on a shelf
Daylina Miller/WUSF

Congressional investigators say wholesale pharmaceutical distributors shipped hundreds of millions of prescription opioid pills to West Virginia, a state disproportionately ravaged by deaths caused by the addictive drugs. Now, lawmakers want executives of those companies to explain how that happened.

Flickr Creative Commons

Facing a rising death toll from drug overdoses, state lawmakers across the country are testing a strategy to boost treatment for opioid addicts: Force drug manufacturers and their distributors to pay for it.

Osceola Sues Drug Companies Over Opioid Epidemic

Apr 24, 2018
Flickr Creative Commons

Osceola County is going after pharmaceutical companies. The county filed a lawsuit against several drug companies.

The city of Jacksonville has taken another step toward suing pharmaceutical companies for their alleged role in the city’s opioid addiction crisis.

Two of Florida’s largest counties, Palm Beach and Broward, have started a process that could take opioid drug makers to court for their roles in the opioid crisis. 

State Targets Pharmaceutical Company In Stock Case

Oct 18, 2017
wp paarz / Flickr

In a rare move, Florida is considering taking on a large pharmaceutical company, alleging the state's pension fund lost more than $62 million in stock value because of federal security violations by the company.

Pharmaceutical Industry Backs 7-Day Limit On Opioids

Sep 28, 2017
Pharmacy Technician amongst two shelves of prescription pills.
Daylina Miller/Health News Florida

As Gov. Rick Scott and legislative leaders start to move forward with plans to address the state's opioid epidemic, a major pharmaceutical-industry group said Wednesday it would support a seven-day limit on initial prescriptions of pain medications.

The City of Jacksonville is moving forward with plans to launch a lawsuit against pharmaceutical companies for their role in the city’s worsening opioid addiction crisis.

More than 30 years ago, Congress overwhelmingly passed a landmark health bill aimed at motivating pharmaceutical companies to develop new drugs for people whose rare diseases had been ignored.

By the drugmakers' calculations, the markets for such diseases weren't big enough to bother with.

Scientists say most antidepressants don't work for children or teenagers with major depression, some may be unsafe, and the quality of evidence about these drugs is so bad the researchers cannot be sure if any are truly effective or safe.

Alejandro Galvis of Aventura, a medical technologist and student in clinical research administration, writes about the outsized power of the pharmaceutical industry in the United States.

Elisabeth Rosenthal of The New York Times, who has been chronicling the reasons why health care in America costs at least twice as much as in other developed countries, turns her attention to drugs. Here she looks at how the manufacturers of asthma drugs and inhalers have maneuvered to protect high prices that bring huge profits -- even as the same drugs and devices sell for only a few dollars in Europe.